media – Page 566 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

EMA accepts MAA for romosozumab in the treatment of osteoporosis

The EMA has accepted the Marketing Authorization Application for romosozumab in the treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture.
- Source: europeanpharmaceuticalreview
- 886
- February 2, 2018
Amgen EMA Evenity (romosozumab) osteoporosis romosozumab
Augmented Reality Helps Surgeons ‘See Through’ Tissue & Reconnect Blood Vessels

Surgeons use Microsoft HoloLens headsets while operating on patients undergoing reconstructive lower limb surgery.
- Source: ODT
- 582
- February 2, 2018
augmented reality medical device Researches surgery
Japanese pharma set for transformation in 2018

This year could see a transformation in the Japanese pharma market, according to a new report, with strong growth stemming from increased use of generics, biosimilars and stronger links with the global industry.
- Source: PharmaPhorum
- 949
- February 2, 2018
biosimilars CPhI Market Views pharmaceutical
Digital health had record funding year, but noticeable drop in exits

In many ways, 2017 was a banner year for digital health funding, according to Rock Health's annual report, which puts funding for the year at a record $5.8 billion.
- Source: Mobi Health News
- 476
- February 2, 2018
digital health investment Market Views
Body clock disruptions occur years before memory loss in Alzheimer’s

Washington University School of Medicine sleep specialist Yo-El Ju, MD, led a research team that found circadian rhythm disruptions occur in people whose memories are intact but whose brain scans show early, preclinical evidence of Alzheimer's disease. She previously had discovered that people with clinical symptoms of Alzheimer's have disturbances in their internal body clocks that affect the sleep/wake cycle. Credit: Washington University School of Medicine.
- Source: medicalxpress
- 620
- February 1, 2018
Alzheimer's disease circadian rhythm disruptions Researches
FDA Clears UC Davis Startup’s Polymer to Aid Bone Regrowth

Molecular Matrix Inc. invented a synthetic bone void filler, Osteo-P, that can help injured bones regrow.
- Source: ODT
- 605
- February 1, 2018
bone FDA medical device
Enzychem Lifesciences Announces the FDA Orphan Drug Designation Granted to EC-18 on Acute Radiation Syndrome (ARS)

Enzychem Lifesciences, announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation to EC-18 for the treatment of Acute Radiation Syndrome (ARS).
- Source: china-pharmacy
- 597
- February 1, 2018
ARS EC-18 FDA Orphan Drug Designation rare diseases
NICE becomes latest champion for digital health

NICE has become the latest organisation to champion digital health, recommending that the NHS should trial an online and mobile programme to treat depression.
- Source: Pharma Phorum
- 746
- February 1, 2018
Company Insight digital health EHR NICE
Seattle Genetics Snaps Up Cascadian in $614M Buyout Deal

The year’s merger-and-acquisition trend continues. Today, the last day of January, Bothell, Washington-based Seattle Genetics announced it is buying Seattle-based Cascadian Therapeutics for about $614 million.
- Source: Biospace
- 460
- February 1, 2018
Cascadian HER2 Market Views merger-and-acquisition
U.K. Startup Medopad Signs Deals with Tencent and Ping An

London-based startup accompanying U.K. Prime Minister on trade mission
- Source: Bloomberg Technology
- 563
- February 1, 2018
AI China Company Insight digital health

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.